GENERAL INFORMATION
Item |
Description |
FORTRAN |
Columns |
Details |
-1 |
Card type |
'A' |
1 |
'GENERAL INFORMATION' |
0 |
Study number |
I6 |
3 - 8 |
|
1 |
Patient identifier |
A12 |
10 - 21 |
|
2 |
Date of birth |
I6 |
23 - 28 |
DDMMYY |
3 |
Case/control status |
I1 |
30 |
Value |
Description |
1 |
Case |
2 |
Control |
|
4 |
Set number |
I6 |
32 - 37 |
|
5 |
(Pseudo)diagnosis date |
I6 |
39 - 44 |
DDMMYY |
6 |
Tumour stage (cases only) |
A2 |
46 - 47 |
|
7 |
Tumour histology (cases only) |
A5 |
49 - 53 |
|
8 |
First detected in a screening programme |
I1 |
55 |
Value |
Description |
1 |
No |
2 |
Mammographically |
3 |
Non-mammographically |
|
9 |
Primary reason for admission |
I4 |
57 - 60 |
|
10 |
Secondary reason for admission |
I4 |
62 - 65 |
|
11 |
ICD revision number |
I1 |
67 |
|
12 |
Ethnic group |
I1 |
69 |
|
13 |
Years of full-time education or equivalent |
I4 |
71 - 74 |
|
14 |
Smoking |
I1 |
76 |
Value |
Description |
1 |
Never |
2 |
Past |
3 |
Current |
|
15 |
Alchohol |
I3 |
78 - 80 |
g/wk |
16 |
Adult height |
I3 |
82 - 84 |
cm |
17 |
Maternal breast cancer history |
I1 |
86 |
Value |
Description |
1 |
No |
2 |
Yes |
|
18 |
Maternal birth year |
I2 |
88 - 89 |
YY |
19 |
Age of mother at diagnosis/now/death |
I2 |
91 - 92 |
|
20 |
Number of sisters |
I2 |
94 - 95 |
|
21 |
Number of sisters with b.c. history |
I1 |
97 |
|
22 |
Number of daughters |
I2 |
99 - 100 |
|
23 |
Number of daughters with b.c. history |
I1 |
102 |
|
24 |
Number of breast biopsies |
I1 |
104 |
|
25 |
Number of screening mammograms |
I1 |
106 |
|
26 |
Menarche age |
I2 |
108 - 109 |
|
27 |
Menarche weight |
I3 |
111 - 113 |
kg |
28 |
Weight aged 20 |
I3 |
115 - 117 |
kg |
29 |
Weight prior to (pseudo)diagnosis |
I3 |
119 - 121 |
kg |
30 |
Menopausal status |
I1 |
123 |
Value |
Description |
1 |
Premenopausal |
2 |
Perimenopausal |
3 |
Postmenopausal |
4 |
Uncertain |
|
31 |
Menopause age |
I2 |
125 - 126 |
|
32 |
Menopause type |
I1 |
128 |
Value |
Description |
1 |
Natural |
2 |
Hysterectomy alone |
3 |
Bilateral oophorectomy
alone |
4 |
Hysterectomy + oophorectomy |
5 |
Irradiation |
6 |
Other |
|
33 |
Hysterectomy |
I1 |
130 |
Value |
Description |
1 |
Yes |
2 |
No |
|
34 |
Hysterectomy age |
I2 |
132 - 133 |
|
35 |
Ovarian status |
I1 |
135 |
Value |
Description |
1 |
Both intact |
2 |
One removed or irradiated |
3 |
Both removed or
irradiated |
4 |
Uncertain |
|
36 |
First ovarian removal age |
I2 |
137 - 138 |
|
37 |
Second ovarian removal age |
I2 |
140 - 141 |
|
38 |
Tubal ligation |
I1 |
143 |
Value |
Description |
1 |
No |
2 |
Yes |
|
39 |
Tubal ligation age |
I2 |
145 - 146 |
|
40 |
Medical infertility
advice |
I1 |
148 |
Value |
Description |
1 |
No |
2 |
Yes |
|
41 |
Total pregnancies |
I2 |
150 - 151 |
|
42 |
Total full-term
pregnancies |
I2 |
153 - 154 |
|
43 |
First full-term
birth age |
I2 |
156 - 157 |
|
44 |
Comments |
A |
159 - end |
|
|
BREAST BIOPSIES
Item |
Description |
FORTRAN |
Columns |
Details |
-1 |
Card type |
'B' |
1 |
'BREAST BIOPSIES' |
0 |
Study number |
I6 |
3 - 8 |
|
1 |
Patient identifier |
A12 |
10 - 21 |
|
2 |
1st breast biopsy
age |
I2 |
23 - 24 |
|
3 |
1st breast biopsy
result |
I1 |
26 |
Value |
Description |
1 |
Normal |
2 |
Abnormal |
|
4 |
2nd breast biopsy
age |
I2 |
28 - 29 |
|
5 |
2nd breast biopsy
result |
I1 |
31 |
Value |
Description |
1 |
Normal |
2 |
Abnormal |
|
6 |
3rd breast biopsy
age |
I2 |
33 - 34 |
|
7 |
3rd breast biopsy
result |
I1 |
36 |
Value |
Description |
1 |
Normal |
2 |
Abnormal |
|
8 |
4th breast biopsy
age |
I2 |
38 - 39 |
|
9 |
4th breast biopsy
result |
I1 |
41 |
Value |
Description |
1 |
Normal |
2 |
Abnormal |
|
10 |
5th breast biopsy
age |
I2 |
43 - 44 |
|
11 |
5th breast biopsy
result |
I1 |
46 |
Value |
Description |
1 |
Normal |
2 |
Abnormal |
|
(continue for further breast biopsies as necessary) |
MAMMOGRAMS
Item |
Description |
FORTRAN |
Columns |
Details |
-1 |
Card type |
'C' |
1 |
'MAMMOGRAMS' |
0 |
Study number |
I6 |
3 - 8 |
|
1 |
Patient identifier |
A12 |
10 - 21 |
|
2 |
1st mammogram age |
I2 |
23 - 24 |
|
3 |
1st mammogram result |
I1 |
26 |
Value |
Description |
1 |
Normal |
2 |
Abnormal |
|
4 |
2nd mammogram age |
I2 |
28 - 29 |
|
5 |
2nd mammogram result |
I1 |
31 |
Value |
Description |
1 |
Normal |
2 |
Abnormal |
|
6 |
3rd mammogram age |
I2 |
33 - 34 |
|
7 |
3rd mammogram result |
I1 |
36 |
Value |
Description |
1 |
Normal |
2 |
Abnormal |
|
8 |
4th mammogram age |
I2 |
38 - 39 |
|
9 |
4th mammogram result |
I1 |
41 |
Value |
Description |
1 |
Normal |
2 |
Abnormal |
|
10 |
5th mammogram age |
I2 |
43 - 44 |
|
11 |
5th mammogram result |
I1 |
46 |
Value |
Description |
1 |
Normal |
2 |
Abnormal |
|
(continue for further mammograms as necessary) |
SISTERS
Item |
Description |
FORTRAN |
Columns |
Details |
-1 |
Card type |
'D' |
1 |
'SISTERS' |
0 |
Study number |
I6 |
3 - 8 |
|
1 |
Patient identifier |
A12 |
10 - 21 |
|
2 |
Sister 1 breast
cancer history |
I1 |
23 |
Value |
Description |
1 |
No |
2 |
Yes |
|
3 |
Sister 1 birth year |
I2 |
25 - 26 |
YY |
4 |
Sister 1 age at
diagnosis/now/death |
I2 |
28 - 29 |
|
5 |
Sister 2 breast
cancer history |
I1 |
31 |
Value |
Description |
1 |
No |
2 |
Yes |
|
6 |
Sister 2 birth year |
I2 |
33 - 34 |
YY |
7 |
Sister 2 age at
diagnosis/now/death |
I2 |
36 - 37 |
|
8 |
Sister 3 breast
cancer history |
I1 |
39 |
Value |
Description |
1 |
No |
2 |
Yes |
|
9 |
Sister 3 birth year |
I2 |
41 - 42 |
YY |
10 |
Sister 3 age at
diagnosis/now/death |
I2 |
44 - 45 |
|
11 |
Sister 4 breast
cancer history |
I1 |
47 |
Value |
Description |
1 |
No |
2 |
Yes |
|
12 |
Sister 4 birth year |
I2 |
49 - 50 |
YY |
13 |
Sister 4 age at
diagnosis/now/death |
I2 |
52 - 53 |
|
14 |
Sister 5 breast
cancer history |
I1 |
55 |
Value |
Description |
1 |
No |
2 |
Yes |
|
11 |
Sister 5 birth year |
I2 |
57 - 58 |
YY |
12 |
Sister 5 age at
diagnosis/now/death |
I2 |
60 - 61 |
|
(continue for further sisters as necessary) |
DAUGHTERS
Item |
Description |
FORTRAN |
Columns |
Details |
-1 |
Card type |
'E' |
1 |
'DAUGHTERS' |
0 |
Study number |
I6 |
3 - 8 |
|
1 |
Patient identifier |
A12 |
10 - 21 |
|
2 |
Daughter 1 breast
cancer history |
I1 |
23 |
Value |
Description |
1 |
No |
2 |
Yes |
|
3 |
Daughter 1 birth
year |
I2 |
25 - 26 |
YY |
4 |
Daughter 1 age at
diagnosis/now/death |
I2 |
28 - 29 |
|
5 |
Daughter 2 breast
cancer history |
I1 |
31 |
Value |
Description |
1 |
No |
2 |
Yes |
|
6 |
Daughter 2 birth
year |
I2 |
33 - 35 |
YY |
7 |
Daughter 2 age at
diagnosis/now/death |
I2 |
37 - 38 |
|
8 |
Daughter 3 breast
cancer history |
I1 |
40 |
Value |
Description |
1 |
No |
2 |
Yes |
|
9 |
Daughter 3 birth
year |
I2 |
41 - 42 |
YY |
10 |
Daughter 3 age at
diagnosis/now/death |
I2 |
44 - 45 |
|
11 |
Daughter 4 breast
cancer history |
I1 |
47 |
Value |
Description |
1 |
No |
2 |
Yes |
|
12 |
Daughter 4 birth
year |
I2 |
49 - 50 |
YY |
13 |
Daughter 4 age at
diagnosis/now/death |
I2 |
52 - 53 |
|
14 |
Daughter 5 breast
cancer history |
I1 |
55 |
Value |
Description |
1 |
No |
2 |
Yes |
|
15 |
Daughter 5 birth
year |
I2 |
57 - 58 |
YY |
16 |
Daughter 5 age at
diagnosis/now/death |
I2 |
60 - 61 |
|
(continue for further daughters as necessary) |
BABY (one
line for each pregnancy or, if multiple birth, for each baby)
Item |
Description |
FORTRAN |
Columns |
Details |
-1 |
Card type |
'F' |
1 |
'BABY' |
0 |
Study number |
I6 |
3 - 8 |
|
1 |
Patient identifier |
A12 |
10 - 21 |
|
2 |
Number of babies
at this delivery |
I1 |
23 |
|
3 |
Delivery/end date |
I6 |
25 - 30 |
DDMMYY |
4 |
Pregnancy weeks |
I2 |
32 - 33 |
|
5 |
Outcome |
I1 |
35 |
Value |
Description |
1 |
Live birth |
2 |
Stillbirth |
3 |
Miscarriage / spontaneous
abortion |
4 |
Termination / induced
abortion |
5 |
Ectopic gestation |
6 |
Hydatiform mole |
|
6 |
Hormones given to
sustain pregnancy |
I1 |
37 |
Value |
Description |
1 |
No |
2 |
Yes |
|
7 |
Months of hormones |
I1 |
39 |
|
8 |
Hormone brand |
I2 |
41 - 42 |
|
9 |
Breastfeeding weeks |
I2 |
44 - 45 |
|
10 |
Lactation suppressed
by hormones |
I1 |
47 |
Value |
Description |
1 |
No |
2 |
Yes |
|
11 |
Baby gender |
I1 |
49 |
Value |
Description |
1 |
Male |
2 |
Female |
|
|
COMBINED ORAL
CONTRACEPTIVES
Item |
Description |
FORTRAN |
Columns |
Details |
-1 |
Card type |
'G' |
1 |
'COMBINED ORAL CONTRACEPTIVES' |
0 |
Study number |
I6 |
3 - 8 |
|
1 |
Patient identifier |
A12 |
10 - 21 |
|
2 |
Date first combined
oral contraceptive |
I4 |
23 - 26 |
MMYY |
3 |
Date last combined
oral contraceptive |
I4 |
28 - 31 |
MMYY |
4 |
Total combined oral
contraceptive months |
I3 |
33 - 35 |
|
5 |
Total use months
pre-1st full-term pregnancy |
I3 |
37 - 39 |
|
6 |
1st brand combined
oral used |
I2 |
41 - 42 |
|
7 |
2nd brand combined
oral used |
I2 |
44 - 45 |
|
8 |
3rd brand combined
oral used |
I2 |
47 - 48 |
|
9 |
4th brand combined
oral used |
I2 |
50 - 51 |
|
10 |
5th brand combined
oral used |
I2 |
53 - 54 |
|
11 |
6th brand combined
oral used |
I2 |
56 - 57 |
|
12 |
7th brand combined
oral used |
I2 |
59 - 60 |
|
13 |
8th brand combined
oral used |
I2 |
62 - 63 |
|
14 |
9th brand combined
oral used |
I2 |
65 - 66 |
|
(continue for further combined oral contraceptives
as necessary) |
PROGESTAGEN-ONLY
CONTRACEPTIVES
Item |
Description |
FORTRAN |
Columns |
Details |
-1 |
Card type |
'H' |
1 |
'PROGESTAGEN-ONLY
ORAL CONTRACEPTIVES' |
0 |
Study number |
I6 |
3 - 8 |
|
1 |
Patient identifier |
A12 |
10 - 21 |
|
2 |
Date first progestagen-only
oral contraceptive |
I4 |
23 - 26 |
MMYY |
3 |
Date last progestagen-only
oral contraceptive |
I4 |
28 - 31 |
MMYY |
4 |
Total progestagen-only
oral months |
I3 |
33 - 35 |
|
5 |
Total use months
pre-1st full-term pregnancy |
I3 |
37 - 39 |
|
6 |
1st brand progestagen-only
oral used |
I2 |
41 - 42 |
|
7 |
2nd brand progestagen-only
oral used |
I2 |
44 - 45 |
|
8 |
3rd brand progestagen-only
oral used |
I2 |
47 - 48 |
|
9 |
4th brand progestagen-only
oral used |
I2 |
50 - 51 |
|
10 |
5th brand progestagen-only
oral used |
I2 |
53 - 54 |
|
11 |
6th brand progestagen-only
oral used |
I2 |
56 - 57 |
|
12 |
7th brand progestagen-only
oral used |
I2 |
59 - 60 |
|
13 |
8th brand progestagen-only
oral used |
I2 |
62 - 63 |
|
14 |
9th brand progestagen-only
oral used |
I2 |
65 - 66 |
|
(continue for further progestagen-only oral
contraceptives as necessary) |
DEPOT PROGESTAGEN
CONTRACEPTIVES
Item |
Description |
FORTRAN |
Columns |
Details |
-1 |
Card type |
'I' |
1 |
'DEPOT PROGESTAGEN
CONTRACEPTIVES' |
0 |
Study number |
I6 |
3 - 8 |
|
1 |
Patient identifier |
A12 |
10 - 21 |
|
2 |
Date first depot
progestagen |
I4 |
23 - 26 |
MMYY |
3 |
Date last depot
progestagen |
I4 |
28 - 31 |
MMYY |
4 |
Total depot progestagen
months |
I3 |
33 - 35 |
|
5 |
Total use months
pre-1st full-term pregnancy |
I3 |
37 - 39 |
|
6 |
1st brand depot
progestagen used |
I2 |
41 - 42 |
|
7 |
2nd brand depot
progestagen used |
I2 |
44 - 45 |
|
8 |
3rd brand depot
progestagen used |
I2 |
47 - 48 |
|
9 |
4th brand depot
progestagen used |
I2 |
50 - 51 |
|
10 |
5th brand depot
progestagen used |
I2 |
53 - 54 |
|
11 |
6th brand depot
progestagen used |
I2 |
56 - 57 |
|
12 |
7th brand depot
progestagen used |
I2 |
59 - 60 |
|
13 |
8th brand depot
progestagen used |
I2 |
62 - 63 |
|
14 |
9th brand depot
progestagen used |
I2 |
65 - 66 |
|
(continue for further depot progestagen contraceptives
as necessary) |
HORMONE REPLACEMENT
THERAPY
Item |
Description |
FORTRAN |
Columns |
Details |
-1 |
Card type |
'J' |
1 |
'HORMONE REPLACEMENT
THERAPY' |
0 |
Study number |
I6 |
3 - 8 |
|
1 |
Patient identifier |
A12 |
10 - 21 |
|
2 |
Date first hormone
replacement therapy |
I4 |
23 - 26 |
MMYY |
3 |
Date last hormone
replacement therapy |
I4 |
28 - 31 |
MMYY |
4 |
Total hormone replacement
therapy months |
I3 |
33 - 35 |
|
5 |
Total use months
pre-1st full-term pregnancy |
I3 |
37 - 39 |
|
6 |
1st brand hormone
replacement therapy |
I2 |
41 - 42 |
|
7 |
2nd brand hormone
replacement therapy |
I2 |
44 - 45 |
|
8 |
3rd brand hormone
replacement therapy |
I2 |
47 - 48 |
|
9 |
4th brand hormone
replacement therapy |
I2 |
50 - 51 |
|
10 |
5th brand hormone
replacement therapy |
I2 |
53 - 54 |
|
11 |
6th brand hormone
replacement therapy |
I2 |
56 - 57 |
|
12 |
7th brand hormone
replacement therapy |
I2 |
59 - 60 |
|
13 |
8th brand hormone
replacement therapy |
I2 |
62 - 63 |
|
14 |
9th brand hormone
replacement therapy |
I2 |
65 - 66 |
|
(continue for further hormone replacement
therapies as necessary) |
FERTILITY-ENHANCING
DRUGS
Item |
Description |
FORTRAN |
Columns |
Details |
-1 |
Card type |
'K' |
1 |
'FERTILITY-ENHANCING
DRUGS' |
0 |
Study number |
I6 |
3 - 8 |
|
1 |
Patient identifier |
A12 |
10 - 21 |
|
2 |
Date first fertility-enhancing
drug |
I4 |
23 - 26 |
MMYY |
3 |
Date last fertility-enhancing
drug |
I4 |
28 - 31 |
MMYY |
4 |
Total fertility-enhancing
drug months |
I3 |
33 - 35 |
|
5 |
Total use months
pre-1st full-term pregnancy |
I3 |
37 - 39 |
|
6 |
1st brand fertility-enhancing
drug |
I2 |
41 - 42 |
|
7 |
2nd brand fertility-enhancing
drug |
I2 |
44 - 45 |
|
8 |
3rd brand fertility-enhancing
drug |
I2 |
47 - 48 |
|
9 |
4th brand fertility-enhancing
drug |
I2 |
50 - 51 |
|
10 |
5th brand fertility-enhancing
drug |
I2 |
53 - 54 |
|
11 |
6th brand fertility-enhancing
drug |
I2 |
56 - 57 |
|
12 |
7th brand fertility-enhancing
drug |
I2 |
59 - 60 |
|
13 |
8th brand fertility-enhancing
drug |
I2 |
62 - 63 |
|
14 |
9th brand fertility-enhancing
drug |
I2 |
65 - 66 |
|
(continue for further fertility-enhancing
drugs as necessary) |
COMBINED ORAL
CONTRACEPTIVE EPISODES
Item |
Description |
FORTRAN |
Columns |
Details |
-1 |
Card type |
'L' |
1 |
'COMBINED ORAL CONTRACEPTIVE
EPISODES' |
0 |
Study number |
I6 |
3 - 8 |
|
1 |
Patient identifier |
A12 |
10 - 21 |
|
2 |
1st combined oral
contraceptive start date |
I4 |
23 - 26 |
MMYY |
3 |
1st combined oral
contraceptive end date |
I4 |
28 - 31 |
MMYY |
4 |
1st combined oral
contraceptive brand |
I2 |
33 - 34 |
|
5 |
2nd combined oral
contraceptive start date |
I4 |
36 - 39 |
MMYY |
6 |
2nd combined oral
contraceptive end date |
I4 |
41 - 44 |
MMYY |
7 |
2nd combined oral
contraceptive brand |
I2 |
46 - 47 |
|
8 |
3rd combined oral
contraceptive start date |
I4 |
49 - 52 |
MMYY |
9 |
3rd combined oral
contraceptive end date |
I4 |
54 - 57 |
MMYY |
10 |
3rd combined oral
contraceptive brand |
I2 |
59 - 60 |
|
11 |
4th combined oral
contraceptive start date |
I4 |
62 - 65 |
MMYY |
12 |
4th combined oral
contraceptive end date |
I4 |
67 - 70 |
MMYY |
13 |
4th combined oral
contraceptive brand |
I2 |
72 - 73 |
|
14 |
5th combined oral
contraceptive start date |
I4 |
75 - 78 |
MMYY |
15 |
5th combined oral
contraceptive end date |
I4 |
80 - 83 |
MMYY |
16 |
5th combined oral
contraceptive brand |
I2 |
85 - 86 |
|
(continue for further combined oral contraceptive
episodes as necessary) |
PROGESTAGEN-ONLY
ORAL CONTRACEPTIVE EPISODES
Item |
Description |
FORTRAN |
Columns |
Details |
-1 |
Card type |
'M' |
1 |
'PROGESTAGEN-ONLY
ORAL CONTRACEPTIVE EPISODES' |
0 |
Study number |
I6 |
3 - 8 |
|
1 |
Patient identifier |
A12 |
10 - 21 |
|
2 |
1st progestagen-only
oral contraceptive start date |
I4 |
23 - 26 |
MMYY |
3 |
1st progestagen-only
oral contraceptive end date |
I4 |
28 - 31 |
MMYY |
4 |
1st progestagen-only
oral contraceptive brand |
I2 |
33 - 34 |
|
5 |
2nd progestagen-only
oral contraceptive start date |
I4 |
36 - 39 |
MMYY |
6 |
2nd progestagen-only
oral contraceptive end date |
I4 |
41 - 44 |
MMYY |
7 |
2nd progestagen-only
oral contraceptive brand |
I2 |
46 - 47 |
|
8 |
3rd progestagen-only
oral contraceptive start date |
I4 |
49 - 52 |
MMYY |
9 |
3rd progestagen-only
oral contraceptive end date |
I4 |
54 - 57 |
MMYY |
10 |
3rd progestagen-only
oral contraceptive brand |
I2 |
59 - 60 |
|
11 |
4th progestagen-only
oral contraceptive start date |
I4 |
62 - 65 |
MMYY |
12 |
4th progestagen-only
oral contraceptive end date |
I4 |
67 - 70 |
MMYY |
13 |
4th progestagen-only
oral contraceptive brand |
I2 |
72 - 73 |
|
14 |
5th progestagen-only
oral contraceptive start date |
I4 |
75 - 78 |
MMYY |
15 |
5th progestagen-only
oral contraceptive end date |
I4 |
80 - 83 |
MMYY |
16 |
5th progestagen-only
oral contraceptive brand |
I2 |
85 - 86 |
|
(continue for further progestagen-only oral
contraceptive episodes as necessary) |
DEPOT PROGESTAGEN
EPISODES
Item |
Description |
FORTRAN |
Columns |
Details |
-1 |
Card type |
'N' |
1 |
'DEPOT PROGESTAGEN
EPISODES' |
0 |
Study number |
I6 |
3 - 8 |
|
1 |
Patient identifier |
A12 |
10 - 21 |
|
2 |
1st depot progestagen
start date |
I4 |
23 - 26 |
MMYY |
3 |
1st depot progestagen
end date |
I4 |
28 - 31 |
MMYY |
4 |
1st depot progestagen
brand |
I2 |
33 - 34 |
|
5 |
2nd depot progestagen
start date |
I4 |
36 - 39 |
MMYY |
6 |
2nd depot progestagen
end date |
I4 |
41 - 44 |
MMYY |
7 |
2nd depot progestagen
brand |
I2 |
46 - 47 |
|
8 |
3rd depot progestagen
start date |
I4 |
49 - 52 |
MMYY |
9 |
3rd depot progestagen
end date |
I4 |
54 - 57 |
MMYY |
10 |
3rd depot progestagen
brand |
I2 |
59 - 60 |
|
11 |
4th depot progestagen
start date |
I4 |
62 - 65 |
MMYY |
12 |
4th depot progestagen
end date |
I4 |
67 - 70 |
MMYY |
13 |
4th depot progestagen
brand |
I2 |
72 - 73 |
|
14 |
5th depot progestagen
start date |
I4 |
75 - 78 |
MMYY |
15 |
5th depot progestagen
end date |
I4 |
80 - 83 |
MMYY |
16 |
5th depot progestagen
brand |
I2 |
85 - 86 |
|
(continue for further combined depot progestagen
contraceptive episodes as necessary) |
HORMONE REPLACEMENT
THERAPY EPISODES
Item |
Description |
FORTRAN |
Columns |
Details |
-1 |
Card type |
'O' |
1 |
'HORMONE REPLACEMENT
THERAPY EPISODES' |
0 |
Study number |
I6 |
3 - 8 |
|
1 |
Patient identifier |
A12 |
10 - 21 |
|
2 |
1st hormone replacement
therapy start date |
I4 |
23 - 26 |
MMYY |
3 |
1st hormone replacement
therapy end date |
I4 |
28 - 31 |
MMYY |
4 |
1st hormone replacement
therapy brand |
I2 |
33 - 34 |
|
5 |
2nd hormone replacement
therapy start date |
I4 |
36 - 39 |
MMYY |
6 |
2nd hormone replacement
therapy end date |
I4 |
41 - 44 |
MMYY |
7 |
2nd hormone replacement
therapy brand |
I2 |
46 - 47 |
|
8 |
3rd hormone replacement
therapy start date |
I4 |
49 - 52 |
MMYY |
9 |
3rd hormone replacement
therapy end date |
I4 |
54 - 57 |
MMYY |
10 |
3rd hormone replacement
therapy brand |
I2 |
59 - 60 |
|
11 |
4th hormone replacement
therapy start date |
I4 |
62 - 65 |
MMYY |
12 |
4th hormone replacement
therapy end date |
I4 |
67 - 70 |
MMYY |
13 |
4th hormone replacement
therapy brand |
I2 |
72 - 73 |
|
14 |
5th hormone replacement
therapy start date |
I4 |
75 - 78 |
MMYY |
15 |
5th hormone replacement
therapy end date |
I4 |
80 - 83 |
MMYY |
16 |
5th hormone replacement
therapy brand |
I2 |
85 - 86 |
|
(continue for further hormone replacement
therapy episodes as necessary) |
FERTILITY-ENHANCING
DRUG EPISODES
Item |
Description |
FORTRAN |
Columns |
Details |
-1 |
Card type |
'P' |
1 |
'FERTILITY-ENHANCING
DRUG EPISODES' |
0 |
Study number |
I6 |
3 - 8 |
|
1 |
Patient identifier |
A12 |
10 - 21 |
|
2 |
1st fertility-enhancing
drug start date |
I4 |
23 - 26 |
MMYY |
3 |
1st fertility-enhancing
drug end date |
I4 |
28 - 31 |
MMYY |
4 |
1st fertility-enhancing
drug brand |
I2 |
33 - 34 |
|
5 |
2nd fertility-enhancing
drug start date |
I4 |
36 - 39 |
MMYY |
6 |
2nd fertility-enhancing
drug end date |
I4 |
41 - 44 |
MMYY |
7 |
2nd fertility-enhancing
drug brand |
I2 |
46 - 47 |
|
8 |
3rd fertility-enhancing
drug start date |
I4 |
49 - 52 |
MMYY |
9 |
3rd fertility-enhancing
drug end date |
I4 |
54 - 57 |
MMYY |
10 |
3rd fertility-enhancing
drug brand |
I2 |
59 - 60 |
|
11 |
4th fertility-enhancing
drug start date |
I4 |
62 - 65 |
MMYY |
12 |
4th fertility-enhancing
drug end date |
I4 |
67 - 70 |
MMYY |
13 |
4th fertility-enhancing
drug brand |
I2 |
72 - 73 |
|
14 |
5th fertility-enhancing
drug start date |
I4 |
75 - 78 |
MMYY |
15 |
5th fertility-enhancing
drug end date |
I4 |
80 - 83 |
MMYY |
16 |
5th fertility-enhancing
drug brand |
I2 |
85 - 86 |
|
(continue for further fertility-enhancing
drug episodes as necessary) |
OTHER-HORMONE
EPISODES
Item |
Description |
FORTRAN |
Columns |
Details |
-1 |
Card type |
'Q' |
1 |
'OTHER-HORMONE EPISODES' |
0 |
Study number |
I6 |
3 - 8 |
|
1 |
Patient identifier |
A12 |
10 - 21 |
|
2 |
Reason for 1st-time
use |
I1 |
23 |
Value |
Description |
1 |
Acne |
2 |
Infertility |
3 |
Period regulation |
4 |
Other |
|
3 |
1st other-hormone
start date |
I4 |
25 - 28 |
MMYY |
4 |
1st other-hormone
end date |
I4 |
30 - 33 |
MMYY |
5 |
1st other-hormone
brand |
I2 |
35 - 36 |
|
6 |
Reason for 2nd-time
use |
I1 |
38 |
Value |
Description |
1 |
Acne |
2 |
Infertility |
3 |
Period regulation |
4 |
Other |
|
7 |
2nd other-hormone
start date |
I4 |
40 - 43 |
MMYY |
8 |
2nd other-hormone
end date |
I4 |
45 - 48 |
MMYY |
9 |
2nd other-hormone
brand |
I2 |
50 - 51 |
|
10 |
Reason for 3rd-time
use |
I1 |
53 |
Value |
Description |
1 |
Acne |
2 |
Infertility |
3 |
Period regulation |
4 |
Other |
|
11 |
3rd other-hormone
start date |
I4 |
55 - 58 |
MMYY |
12 |
3rd other-hormone
end date |
I4 |
60 - 63 |
MMYY |
13 |
3rd other-hormone
brand |
I2 |
65 - 66 |
|
14 |
Reason for 4th-time
use |
I1 |
68 |
Value |
Description |
1 |
Acne |
2 |
Infertility |
3 |
Period regulation |
4 |
Other |
|
15 |
4th other-hormone
start date |
I4 |
70 - 73 |
MMYY |
16 |
4th other-hormone
end date |
I4 |
75 - 78 |
MMYY |
17 |
4th other-hormone
brand |
I2 |
80 - 81 |
|
18 |
Reason for 5th-time
use |
I1 |
83 |
Value |
Description |
1 |
Acne |
2 |
Infertility |
3 |
Period regulation |
4 |
Other |
|
19 |
5th other-hormone
start date |
I4 |
85 - 88 |
MMYY |
20 |
5th other-hormone
end date |
I4 |
90 - 93 |
MMYY |
21 |
5th other-hormone
brand |
I2 |
95 - 96 |
|
(continue for further other-hormone episodes
as necessary) |